Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Return on Capital Employed (2020 - 2023)

Historic Return on Capital Employed for SELLAS Life Sciences (SLS) over the last 6 years, with Q4 2023 value amounting to 5.75%.

  • SELLAS Life Sciences' Return on Capital Employed rose 110300.0% to 5.75% in Q4 2023 from the same period last year, while for Dec 2023 it was 5.75%, marking a year-over-year increase of 110300.0%. This contributed to the annual value of 245.9% for FY2023, which is 2510900.0% up from last year.
  • As of Q4 2023, SELLAS Life Sciences' Return on Capital Employed stood at 5.75%, which was up 110300.0% from 24.6% recorded in Q3 2023.
  • SELLAS Life Sciences' Return on Capital Employed's 5-year high stood at 5.75% during Q4 2023, with a 5-year trough of 24.6% in Q3 2023.
  • Its 4-year average for Return on Capital Employed is 3.87%, with a median of 2.83% in 2022.
  • Examining YoY changes over the last 5 years, SELLAS Life Sciences' Return on Capital Employed showed a top increase of 110300bps in 2023 and a maximum decrease of -219300bps in 2023.
  • Over the past 4 years, SELLAS Life Sciences' Return on Capital Employed (Quarter) stood at 0.85% in 2020, then dropped by -9bps to 0.93% in 2021, then crashed by -466bps to 5.27% in 2022, then skyrocketed by 209bps to 5.75% in 2023.
  • Its Return on Capital Employed stands at 5.75% for Q4 2023, versus 24.6% for Q3 2023 and 3.55% for Q2 2023.